Bryan M. Reasons's Net Worth
$2.17 Million
Who is Bryan M. Reasons?
Bryan M. Reasons has an estimated net worth of $2.17 Million. This is based on reported shares across multiple companies, which include Aclaris Therapeutics, Inc., Amneal Pharmaceuticals, Inc., Societal CDMO, Inc., Mallinckrodt plc, and IMPAX LABORATORIES INC.
SEC CIK
Bryan M. Reasons's CIK is 0001553489
Past Insider Trading and Trends
2018 was Bryan M. Reasons's most active year for acquiring shares with 13 total transactions. Bryan M. Reasons's most active month to acquire stocks was the month of April. 2018 was Bryan M. Reasons's most active year for disposing of shares, totalling 11 transactions. Bryan M. Reasons's most active month to dispose stocks was the month of April. 2019 saw Bryan M. Reasons paying a total of $48,383.46 for 110,880 shares, this is the most they've acquired in one year. In 2018 Bryan M. Reasons cashed out on 377,573 shares for a total of $465,157.15, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.36% | 4.66K |
—
|
—
| 28.73K |
Jun 1
| |||
Form 4
| +23.04% | 4.51K |
—
|
—
| 24.07K |
Jun 1 - Jun 2
| |||
Form 4
| +20.70% | 3.36K |
—
|
—
| 19.57K |
Jun 2 - Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +82.62% | 7.33K |
—
|
—
| 16.21K |
Jun 4 - Jun 6
| |||
Form 4
|
∞
| 8.88K |
—
|
—
| 8.88K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $8.39
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.35% | -11.70K |
$23.65 | -$276,657.70 | 82.99K |
Aug 21
| |||
Form 4
|
∞
| 94.68K |
—
|
—
| 94.68K |
May 4 - May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Societal CDMO, Inc. (SCTL) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -291.05K |
$1.10 | -$320,153.90 |
0
|
Apr 8
| |||
Form 4
| +27.35% | 62.5K |
$0.40 | $25,000.00 | 291.05K |
Aug 28
| |||
Form 4
| +47.52% | 73.62K |
—
|
—
| 228.55K |
May 17
| |||
Form 4
| +129.77% | 87.5K |
—
|
—
| 154.93K |
May 18
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 4
| +66.47% | 26.92K |
—
|
—
| 67.43K |
Apr 20
| |||
Form 4
| +26.02% | 8.36K |
—
|
—
| 40.51K |
May 7
| |||
Form 4
| +39.83% | 9.16K |
—
|
—
| 32.14K |
Dec 5
| |||
Form 4
| +52.92% | 7.96K |
—
|
—
| 22.99K |
May 9
| |||
Form 4
| +143.12% | 8.85K |
—
|
—
| 15.03K |
May 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
∞
| 6.18K |
—
|
—
| 6.18K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mallinckrodt plc (MNKTQ) Snapshot price: $0.04
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| -100.00% | -96.66K |
—
|
—
|
0
|
Nov 14
| |||
Form 4
| -14.18% | -15.98K |
$0.69 | -$11,071.37 | 96.66K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
∞
| 112.64K |
—
|
—
| 112.64K |
Dec 14
| |||
Form 4
| -100.00% | -11.59K |
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -31.78% | -5.40K |
$0.17 | -$891.00 | 11.59K |
Dec 3
| |||
Form 4
| -5.48% | -986.00 |
$1.93 | -$1,902.98 | 16.99K |
Apr 1
| |||
Form 4
| +42.93% | 5.4K |
$8.96 | $48,383.46 | 17.98K |
Jun 7
| |||
Form 4
|
∞
| 12.58K |
—
|
—
| 12.58K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IMPAX LABORATORIES INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -73.99K |
—
|
—
|
0
|
May 4
| |||
Form 4
| -3.14% | -3.07K |
$19.50 | -$59,845.50 | 94.68K |
Mar 2
| |||
Form 4
| -5.91% | -6.14K |
$20.95 | -$128,653.95 | 97.75K |
Feb 26
| |||
Form 4
| -1.10% | -1.16K |
$17.32 | -$20,070.45 | 103.89K |
May 14 - May 15
| |||
Form 4
| +28.46% | 23.27K |
—
|
—
| 105.05K |
Mar 2
| |||
Form 4
| -6.53% | -5.71K |
$14.05 | -$80,295.75 | 81.78K |
Feb 26
| |||
Form 4
| -1.36% | -1.21K |
$21.35 | -$25,812.15 | 87.5K |
Oct 26
| |||
Form 4
| -3.38% | -3.10K |
$29.18 | -$90,603.90 | 88.7K |
May 14 - May 15
| |||
Form 4
| -1.11% | -1.03K |
$35.35 | -$36,587.25 | 91.81K |
Apr 13
| |||
Form 4
| +35.17% | 24.16K |
$33.27 | -$65,142.66 | 92.84K |
Feb 26
| |||
Form 4
| -1.86% | -1.30K |
$35.97 | -$46,725.03 | 68.69K |
Oct 26
| |||
Form 4
| -1.95% | -1.39K |
$44.44 | -$61,816.04 | 69.99K |
May 15
| |||
Form 4
| -2.94% | -2.16K |
$44.82 | -$96,856.02 | 71.38K |
May 14
| |||
Form 4
| -1.61% | -1.21K |
$50.90 | -$61,334.50 | 73.54K |
Apr 13
| |||
Form 4
| +36.53% | 20K |
—
|
—
| 74.75K |
Feb 26
| |||
Form 4
| -1.69% | -940.00 |
$27.80 | -$26,132.00 | 54.75K |
Oct 26
| |||
Form 4
| +63.37% | 21.6K |
$25.56 | -$35,784.00 | 55.69K |
May 14 - May 15
| |||
Form 4
| -3.44% | -1.22K |
$24.55 | -$29,852.80 | 34.09K |
Apr 13
| |||
Form 4
| -2.59% | -939.00 |
$20.47 | -$19,221.33 | 35.3K |
Oct 26
| |||
Form 4
| +69.03% | 14.8K |
—
|
—
| 36.24K |
May 15
| |||
Form 4
| -5.13% | -1.16K |
$16.46 | -$19,077.14 | 21.44K |
Apr 13
| |||
Form 4
| +79.37% | 10K |
—
|
—
| 22.6K |
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |